Humanized antibodies that recognize beta amyloid peptide

Details for Australian Patent Application No. 2007231637 (hide)

Owner Wyeth LLC Janssen Alzheimer Immunotherapy

Inventors Basei, Guriq; Schenk, Dale B.; Saldanha, Jose

Agent Spruson & Ferguson

Pub. Number AU-B-2007231637

Parent 2002225921

Filing date 24 October 2007

Wipo publication date 15 November 2007

Acceptance publication date 24 November 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

8 November 2007 Complete Application Filed

15 November 2007 Application Open to Public Inspection

  Published as AU-B-2007231637

23 October 2008 Amendment Made

  The nature of the amendment is: Amend the co-inventor tname from Yednock, Ted to Schenk, Dale B.

8 April 2010 Alteration of Name

  The name of the applicant has been altered to Elan Pharma International Limited; Wyeth LLC

19 May 2011 Assignment before Grant

  Elan Pharma International Limited; Wyeth LLC The application has been assigned to Wyeth LLC; Janssen Alzheimer Immunotherapy

24 November 2011 Application Accepted

  Published as AU-B-2007231637

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007231638-Humanized antibodies that recognize beta amyloid peptide

2007231636-Optical code reading device having more than one imaging engine